ArticleCurrent oncology (Toronto, Ont.)2022

Cytomegalovirus Retinitis and Retinal Detachment following Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory Multiple Myeloma.

Cheng Zu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.